Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphedema 2Neoplasms 1Menorrhagia 1

Interventions

estradiol, norethindrone drug combination 9elagolix 7Estradiol 7asoprisnil 6Uterine Artery Embolization 6relugolix 5Norethindrone Acetate 5vilaprisan 4Uterine Myomectomy 4linzagolix 2Tranexamic Acid 2ziprasidone 1ulipristal acetate 1ulipristal 1pycnogenols 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Radiofrequency Ablation 1Progesterone 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Menorrhagia × pycnogenols × Clear all
NCT03704454 2018-10-12

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

Legacy Health System

Phase NA Unknown
40 enrolled

Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡